<DOC>
	<DOC>NCT00169728</DOC>
	<brief_summary>The purpose of this study is to determine the immunogenicity and tolerability of the DTaP-IPV-HBV/Hib combination vaccine Infanrix hexa and the heptavalent pneumococcal conjugate vaccine Prevenar in pediatric recipients of allogeneic haematopoietic stem cell transplantation.</brief_summary>
	<brief_title>Vaccination of Children Following Allogeneic Stem Cell Transplantation</brief_title>
	<detailed_description />
	<mesh_term>Vaccines</mesh_term>
	<mesh_term>Heptavalent Pneumococcal Conjugate Vaccine</mesh_term>
	<criteria>pediatric recipient of allogeneic haematopoietic stem cell transplantation complete remission of underlying malignant disease (if applicable) stable haematopoietic engraftment Lansky/Karnofskyscore &gt;= 60% primary immunodeficiency hepatitis B or C, HIV infection application of radio/ chemotherapy following stem cell transplantation extended chronic graftversushost disease (Karnofskyscale &lt; 60%) coagulopathy known allergy/hypersensitivity towards ingredients of study vaccines seizure disorder, progressive neurologic disease</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>17 Years</maximum_age>
	<verification_date>June 2012</verification_date>
	<keyword>allogeneic haematopoietic stem cell transplantation</keyword>
	<keyword>bone marrow transplantation</keyword>
	<keyword>children</keyword>
	<keyword>vaccination</keyword>
	<keyword>invasive pneumococcal disease</keyword>
	<keyword>tetanus</keyword>
	<keyword>diphtheria</keyword>
	<keyword>poliomyelitis</keyword>
	<keyword>pertussis</keyword>
	<keyword>Hepatitis B</keyword>
	<keyword>Haemophilus influenzae type B infection</keyword>
</DOC>